Open Access

The Marshall Journal of Medicine conforms to the Budapest Open Access Initiative (BOAI) funding model. See https://www.budapestopenaccessinitiative.org/. All content to the MJM is freely available to individuals and institutions without an embargo period. Users may "read, download, copy, distribute, print, search, or link to the full text of the articles." Each article accepted by peer review is published under a Creative Commons Attribution License (CC-BY) https://creativecommons.org/licenses/by/4.0/. There is no charge for submitting a manuscript to the journal.

Authors of original work accepted for publication in the Marshall Journal of Medicine ("MJM") will be distributed by the journal under a Creative Commons Attribution License (CC-BY) (https://creativecommons.org/licenses/by/4.0/). This license allows others (third parties) to distribute, remix, tweak, and build upon the author's work, even commercially, as long as they provide appropriate attribution (credit) to the author for the original creation and are not using the work for any commercial purpose. If the author, at any time, believes that the author's work has been published on the MJM website in a way that constitutes copyright infringement, or the author's intellectual property rights have otherwise been compromised or violated, the author must notify immediately.

Discovery and Digital Archiving

The Marshall Journal of Medicine (MJM) participates in industry-standard discovery and preservation tools. Articles from the journal are placed (distributed) in the world's major library catalogs and databases (OCLC Worldcat, ProQuest's Summon, Ex Libris's Primo, and EBSCO Discovery). Articles also receive Digital Object Identifiers (DOIs) from the CrossRef organization to ensure they can always be found.

Peer Review Policy

The MJM strictly adheres to the criteria specified by COPE, OASPA, WAME and DOAJ for ethical scholarly publishing with maximum transparency. The Journal's policy is to have manuscripts reviewed by three expert reviewers in addition to a member of the Journal's Editorial Board. The Marshall Journal of Medicine (MJM) utilizes a double-blind peer review process in which the reviewer's name and personal information (such as employer, institutional affiliation, etc.) is withheld from the author and the author's name and information (such as employer, institutional affiliation, etc.) is withheld from the reviewers.

Publishing Agreement

Articles published in Marshall Journal of Medicine (MJM) are freely available under the Creative Commons Attribution License (CC-BY). The Creative Commons Attribution License allows others to re-use the work without permission as long as the work is properly cited ( proper attribution is made) and the work is not used for commercial purposes. For more information, visit the Creative Commons licenses page at https://creativecommons.org/licenses/.


It is the responsibility of each author to obtain permission from copyright holders for reproducing illustrations, tables, figures, or lengthy quotations. This includes copyright of the author's own material. Papers without correct permissions will not be published. Each author is required to submit the documentation of permission before final peer review of a submission.

Declaration of Conflicting Interests

It is the policy of The Marshall Journal of Medicine (MJM) to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles. A statement of "Declaration of Conflicting Interests" is included at the end of each author's manuscript, after any acknowledgments and prior to the paper's references. If no conflict exists, the Author signs the declaration: "The Author(s) declare(s) that there is no conflict of interest." MJM follows the ICMJE recommendations for guidance concerning conflicts of interest.

Research Ethics and Patient Consent

Medical research involving human subjects must be conducted according to the World Medical Association (WMA) Declaration of Helsinki, ethical principles for medical research involving human subjects. See WMA declaration of Helsinki – ethical principles for medical research involving human subjects (available at https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/). Submitted manuscripts should conform to the International Committee of Medical Journal Editors Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. See ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (available at: http://www.icmje.org/recommendations/). Any paper that is reporting and/or includes a report on animal and/or human studies must include a statement in the methods section that the relevant Ethics Committee or Institutional Review Board (IRB) approval or waiver (if applicable) was received. The author must include in the full name, address and institution for each IRB or other review committee and the approval number. For research articles, authors are also required to include a statement in the methods section addressing informed consent and, whether human participants in the research project provided informed consent as well as the manner in which the consent was recorded (written or verbal). If patient information and/or patient images are a part of the submission the author must provided a statement concerning the informed consent having been provided by the individual and/or his/her legal representative providing permission to use and publish that personal information (patient information and images). Please also refer to the ICMJE Recommendations for the Protection of Research Participants (available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html.) All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility at which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors. See International Association of Veterinary Editors, Guidelines, available at http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors.


The Marshall Journal of Medicine take issues of copyright infringement, plagiarism or other breaches of best practice(s) in publication very seriously. All claims of plagiarism or misuse are investigated. It is the goal of the MJM to protect the rights of authors. Equally, we seek to protect the reputation of the journal against malpractice and unethical conduct. All submissions are checked for plagiarism through available means such as with duplication-checking software. Where an article is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgment, or where the authorship of the article is contested, MJM reserves the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; addressing the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; and/or taking appropriate legal action.

Advertising Policy

  1. The Marshall Journal of Medicine (MJM) has the exclusive discretionary authority to accept or reject any request for advertisement as well as to provide guidelines for acceptable advertisement submissions.
  2. All advertisements are subject to the approval of the MJM, which reserves the right to accept, reject or cancel any advertisement at any time. Any advertisement may be taken down from any media platform without prior notice. The advertisement source will be notified of the Journal's decisions(s).
  3. All advertisements are accepted and published by the MJM solely with and on the warranty of the advertising/source agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
  4. In consideration of publication of an advertisement, the advertiser and the advertising agency/source, expressly jointly and severally, agree to indemnify and hold harmless the MJM, its officers, directors, agents and employees against expenses (including legal fees), costs and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement or plagiarism.
  5. MJM has the sole discretion as to when to publish an accepted advertisement and it will not be liable for any failure to publish any advertisement accepted by it. MJM will use reasonable efforts to place an accepted advertisement in available space.
  6. All advertisements must clearly and prominently identify the advertiser by trademark or signature. Each advertising agency/source must make proper attribution to source materials referenced in any advertisement in accordance with, by example, copyright laws.
  7. MJM has sole discretion with respect to advertisement pricing.
  8. Any references to the MJM, Marshall University and/or its affiliates and divisions, its products or services in advertisements, promotional material, or merchandising by the advertiser or advertising agency/source is subject to MJM or its authorized representative's prior written approval for such use. This includes any links to another Marshall University web page or location site. Any unauthorized linking is prohibited. Marshall Medical Journal does not endorse or support any product or organization linked to its website, nor is MJM responsible for the content of any website promoted in an advertisement. The use by the advertising agency/source of pixels, beacons, cookies, tracking tags, or similar technology for the purpose of collecting personally identifiable information is prohibited.
  9. Each advertisement contract position clause is treated as a request only as MJM cannot and does not guarantee fixed positioning.
  10. MJM is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
  11. MJM may change the terms in this policy at any time. Any policy changes shall apply prospectively and not to advertisements that are in current publication.
  12. MJM shall establish terms and conditions of sale and consequences of nonpayment for a product and publish those to the advertising agency/source prior to publication and, as a condition precedent, each advertising agency/source is jointly and severally liable for any nonpayment.
  13. Proprietary names of any commercial product such as pharmaceuticals must comply with FDA and other regulatory compliance mandates and regulations. The advertising agency/source represents and warrants that all advertisements and commercial products such as pharmaceuticals which are contained with advertisements are compliant with all applicable laws, rules, and regulations in the country where the advertisement will be seen.
  14. Any recruiting advertisement must comply with all applicable laws and regulations in the country in which the advertisement will be seen; any advertisement that discriminates against applicants based on protected class such as sex, age, race, religion, marital status or physical handicap will not be accepted. Each recruiting advertisement must contain the language that the employer is an Equal Opportunity Employer.

Data Sharing Policy

Data Sharing, meaning the sharing of information and data from diverse points of view and sources, is one aspect of The Marshall Journal of Medicine's (MJM) commitment to an open landscape in data and research information exchange. The MJM promotes an open research landscape, facilitating faster and more effective research discovery by enabling reproducibility and verification of data, methodology and reporting standards. MJM encourages authors to share the data and other artefacts supporting results reported by archiving those original sources in an appropriate public repository. Authors may provide a data availability statement, including a link to repository(ies) used and when they do so, this statement can be published in their paper.

Shared data should be cited. All accepted manuscripts may elect to publish a data availability statement to confirm the presence or absence of shared data. If an author has shared data, the paper will include a data sharing statement that describes how the data can be accessed and at least one persistent identifier such as a DOI for the data, or an accession number so that the select repository may be accessed.

{ top }